Giuseppe Galletti

3.3k total citations
24 papers, 775 citations indexed

About

Giuseppe Galletti is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Molecular Biology. According to data from OpenAlex, Giuseppe Galletti has authored 24 papers receiving a total of 775 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Pulmonary and Respiratory Medicine, 11 papers in Oncology and 8 papers in Molecular Biology. Recurrent topics in Giuseppe Galletti's work include Prostate Cancer Treatment and Research (11 papers), Cancer Genomics and Diagnostics (6 papers) and Ubiquitin and proteasome pathways (5 papers). Giuseppe Galletti is often cited by papers focused on Prostate Cancer Treatment and Research (11 papers), Cancer Genomics and Diagnostics (6 papers) and Ubiquitin and proteasome pathways (5 papers). Giuseppe Galletti collaborates with scholars based in United States, Italy and Canada. Giuseppe Galletti's co-authors include Scott T. Tagawa, Paraskevi Giannakakou, Linda Lam, Benjamin I. Leach, Brian J. Kirby, David M. Nanus, Joshua E. Allen, Kaitlyn Gayvert, Martin Stogniew and Neel S. Madhukar and has published in prestigious journals such as Nature Communications, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

In The Last Decade

Giuseppe Galletti

23 papers receiving 767 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Giuseppe Galletti United States 11 385 312 241 229 91 24 775
Sigrun Erkens‐Schulze Netherlands 14 315 0.8× 231 0.7× 238 1.0× 178 0.8× 91 1.0× 20 620
Colleen Mathis United States 8 348 0.9× 330 1.1× 201 0.8× 151 0.7× 31 0.3× 8 675
Brent M. Kuenzi United States 13 130 0.3× 524 1.7× 331 1.4× 109 0.5× 76 0.8× 22 923
Charles Pottier Belgium 14 218 0.6× 539 1.7× 362 1.5× 299 1.3× 40 0.4× 15 1.0k
Daisaku Morita Japan 11 310 0.8× 343 1.1× 274 1.1× 138 0.6× 17 0.2× 20 809
Shane O’Grady Ireland 12 125 0.3× 611 2.0× 365 1.5× 222 1.0× 39 0.4× 19 996
Xun Bao United States 16 187 0.5× 503 1.6× 299 1.2× 213 0.9× 58 0.6× 42 953
Alessia Noto Italy 17 199 0.5× 479 1.5× 289 1.2× 370 1.6× 30 0.3× 18 936
Jim Sang United States 16 274 0.7× 1.0k 3.2× 289 1.2× 95 0.4× 27 0.3× 21 1.2k
Rachel M. Webster United States 13 100 0.3× 330 1.1× 359 1.5× 107 0.5× 133 1.5× 29 767

Countries citing papers authored by Giuseppe Galletti

Since Specialization
Citations

This map shows the geographic impact of Giuseppe Galletti's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Giuseppe Galletti with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Giuseppe Galletti more than expected).

Fields of papers citing papers by Giuseppe Galletti

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Giuseppe Galletti. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Giuseppe Galletti. The network helps show where Giuseppe Galletti may publish in the future.

Co-authorship network of co-authors of Giuseppe Galletti

This figure shows the co-authorship network connecting the top 25 collaborators of Giuseppe Galletti. A scholar is included among the top collaborators of Giuseppe Galletti based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Giuseppe Galletti. Giuseppe Galletti is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Cheema, Parneet, Sylvia Hartl, Marianna Koczywas, et al.. (2023). 695 Efficacy and safety of trastuzumab deruxtecan (T-DXd) with durvalumab in patients with non-small cell lung cancer (HER2 altered NSCLC) who progressed on anti-PD1/PD-L1 therapy (HUDSON). SHILAP Revista de lepidopterología. A787–A787. 5 indexed citations
2.
Zhang, Jiaren, Giuseppe Galletti, Susan Halabi, et al.. (2022). Association of circulating tumor cell RB1 loss RNA signature with outcomes and immune phenotypes in men with mCRPC.. Journal of Clinical Oncology. 40(6_suppl). 139–139.
3.
Gjyrezi, Ada, Giuseppe Galletti, Jiaren Zhang, et al.. (2021). Androgen receptor variant shows heterogeneous expression in prostate cancer according to differentiation stage. Communications Biology. 4(1). 785–785. 5 indexed citations
4.
Thakkar, Prashant V., Katsuhiro Kita, Urko del Castillo, et al.. (2021). CLIP-170S is a microtubule +TIP variant that confers resistance to taxanes by impairing drug-target engagement. Developmental Cell. 56(23). 3264–3275.e7. 7 indexed citations
5.
Galletti, Giuseppe, Chao Zhang, Ada Gjyrezi, et al.. (2020). Microtubule Engagement with Taxane Is Altered in Taxane-Resistant Gastric Cancer. Clinical Cancer Research. 26(14). 3771–3783. 24 indexed citations
6.
7.
Madhukar, Neel S., Prashant K. Khade, Linda Huang, et al.. (2019). A Bayesian machine learning approach for drug target identification using diverse data types. Nature Communications. 10(1). 161 indexed citations
8.
Worroll, Daniel, Giuseppe Galletti, Ada Gjyrezi, et al.. (2019). Androgen receptor nuclear localization correlates with AR-V7 mRNA expression in circulating tumor cells (CTCs) from metastatic castration resistance prostate cancer patients. Physical Biology. 16(3). 36003–36003. 13 indexed citations
9.
Gjyrezi, Ada, Giuseppe Galletti, Jiaren Zhang, et al.. (2019). Abstract 451: Transferrin Receptor identifies a distinct pool of circulating tumor cells from metastatic prostate cancer patients with unique molecular profiles enriched in AR variants. Cancer Research. 79(13_Supplement). 451–451. 1 indexed citations
10.
Tagawa, Scott T., Emmanuel S. Antonarakis, Ada Gjyrezi, et al.. (2018). Expression of AR-V7 and ARv567es in Circulating Tumor Cells Correlates with Outcomes to Taxane Therapy in Men with Metastatic Prostate Cancer Treated in TAXYNERGY. Clinical Cancer Research. 25(6). 1880–1888. 86 indexed citations
11.
Armstrong, Andrew J., Susan Halabi, Jun Luo, et al.. (2018). The PROPHECY trial: Multicenter prospective trial of circulating tumor cell (CTC) AR-V7 detection in men with mCRPC receiving abiraterone (A) or enzalutamide (E).. Journal of Clinical Oncology. 36(15_suppl). 5004–5004. 10 indexed citations
12.
Galletti, Giuseppe, Benjamin I. Leach, Linda Lam, & Scott T. Tagawa. (2017). Mechanisms of resistance to systemic therapy in metastatic castration-resistant prostate cancer. Cancer Treatment Reviews. 57. 16–27. 165 indexed citations
13.
Galletti, Giuseppe, Daniel Worroll, David M. Nanus, & Paraskevi Giannakakou. (2017). Using circulating tumor cells to advance precision medicine in prostate cancer. Journal of Cancer Metastasis and Treatment. 3(9). 190–190. 8 indexed citations
14.
Galletti, Giuseppe, Alexandre Matov, Himisha Beltran, et al.. (2014). ERG induces taxane resistance in castration-resistant prostate cancer. Nature Communications. 5(1). 5548–5548. 97 indexed citations
15.
Galletti, Giuseppe, Luigi Portella, Scott T. Tagawa, et al.. (2014). Circulating Tumor Cells in Prostate Cancer Diagnosis and Monitoring: An Appraisal of Clinical Potential. Molecular Diagnosis & Therapy. 18(4). 389–402. 47 indexed citations
16.
Galletti, Giuseppe, Matthew Sung, Linda T. Vahdat, et al.. (2013). Isolation of breast cancer and gastric cancer circulating tumor cells by use of an anti HER2-based microfluidic device. Lab on a Chip. 14(1). 147–156. 90 indexed citations
17.
Galletti, Giuseppe, Himisha Beltran, Alexandre Matov, et al.. (2013). Abstract LB-59: ERG induces taxane resistance in castration-resistant prostate cancer.. Cancer Research. 73(8_Supplement). LB–59. 2 indexed citations
18.
Altavilla, Giuseppe, et al.. (2010). EML4-ALK fusion gene in lung adenocarcinoma: A retrospective analysis of the outcome of cisplatin plus pemetrexed treated patients.. Journal of Clinical Oncology. 28(15_suppl). 7610–7610. 12 indexed citations
19.
Altavilla, Giuseppe, et al.. (2009). Amplification and overexpression of the PSMB5 gene contributes to bortezomib resistance in retreatment of patients with multiple myeloma. Journal of Clinical Oncology. 27(15_suppl). e19500–e19500. 1 indexed citations
20.
Altavilla, Giuseppe, et al.. (2008). Erlotinib therapy in a patient with non-small-cell lung cancer and brain metastases. Journal of Neuro-Oncology. 90(1). 31–33. 20 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Sigrun Erkens‐Schulze Breakdown of academic impact, for papers by Colleen Mathis Breakdown of academic impact, for papers by Brent M. Kuenzi Breakdown of academic impact, for papers by Charles Pottier Breakdown of academic impact, for papers by Daisaku Morita Breakdown of academic impact, for papers by Shane O’Grady Breakdown of academic impact, for papers by Xun Bao Breakdown of academic impact, for papers by Alessia Noto Breakdown of academic impact, for papers by Jim Sang Breakdown of academic impact, for papers by Rachel M. Webster
Rankless by CCL
2026